ArticleThe American journal of hospice & palliative care2019
Medicare Cost at End of Life.
Article in The American journal of hospice & palliative care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Economic Evaluation of 'Watch and Wait' Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer: A Systematic Review.Annals of surgical oncology · 2025Pooled it
- Comparison of Health Care Cost Trajectories in the Last Year of Life by Age at Death.JAMA network open · 2026Article
- Identifying independent risk factors of mortality among patients receiving a leadless pacemaker: A longitudinal retrospective study in a single center.Heart rhythm O2 · 2026Article
- End-of-life issues in older adults: Emotional and social factors that shape end-of-life experiences.Advances in psychiatry and behavioral health · 2025Article
- Cost-Effectiveness of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025Article
- Advance care planning discussions - Perspectives from oncology patients with advanced-stage disease.Palliative & supportive care · 2025Article
- Incremental Healthcare Costs of Dementia and Cognitive Impairment in Community-Dwelling Older Adults: A Prospective Cohort Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2025Article
- Relationship between handgrip strength and timed up-and-go test on hospitalization costs in older adults: a population-based study.BMC public health · 2025Article
- Improving Policy and Practices of Hospice Live Discharge: A Historical Exploration of the Medicare Hospice Benefit.Journal of aging & social policy · 2025Article
- Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States.Therapeutic advances in medical oncology · 2025Article
- Cost-effectiveness of sequential treatment strategies involving first-line pembrolizumab with trastuzumab and chemotherapy for unresectable metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.Therapeutic advances in medical oncology · 2025Article
- The impact of end-of-life disability level on middle-aged and older adults' utilization of medical services.Frontiers in public health · 2025Article
- Paying for advance care planning in medicare: Impacts on care and spending near end of life.Journal of health economics · 2024Article
- Cost Offset of Dapagliflozin in the US Medicare Population with Cardio-Kidney Metabolic Syndrome.Advances in therapy · 2024Article
- End-of-life expenditure on health care for the older population: a scoping review.Health economics review · 2024Article
- Article
- Rethinking Medical Aid in Dying: What Does It Mean to 'Do No Harm?'Journal of the advanced practitioner in oncology · 2023Review
- Elevated end-of-life spending: A new measure of potentially wasteful health care spending at the end of life.Health services research · 2023Article
- Unique characteristics of end-of-life hospitalizations in Parkinson disease.Frontiers in aging neuroscience · 2023Article
- The High Cost of Death After Acute Myocardial Infarctions: Results from a National US Hospital Database.ClinicoEconomics and outcomes research : CEOR · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As the Medicare program struggles to control expenditures, there is increased focus on opportunities to manage patient populations more efficiently and at a lower cost. A major source of expense for the Medicare program is beneficiaries at end of life. Estimates of the percentage of Medicare costs that arise from patients in the last year of life differ, ranging from 13% to 25%, depending on methods and assumptions. We analyze the most recently available Medicare Limited Data Set to update prior studies of end-of-life costs and examine different methods of performing this calculation. Based upon these findings, we conclude that higher estimates that take into account the spending over the 12 months leading up to death more accurately reflect the full cost of a patient's last year of life. Comparing current year costs of decedents with Medicare's current year costs understates the full budgetary impact of end-of-life patients. Because risk-taking entities such as Medicare Advantage plans and Accountable Care Organizations (ACOs) need to reduce costs while improving the quality of care, they should initiate programs to better manage the care of patients with serious or advanced illness. We also calculate costs for beneficiaries dying in different settings and conclude that more effective use of palliative care and hospice benefits offers a lower cost, higher quality alternative for patients at end of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.